Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Hoofdauteur: | Akter, Anika |
---|---|
Andere auteurs: | Alam, Marzia |
Formaat: | Thesis |
Taal: | English |
Gepubliceerd in: |
Brac University
2022
|
Onderwerpen: | |
Online toegang: | http://hdl.handle.net/10361/17039 |
Gelijkaardige items
-
Biologics and Biosimilars as Treatment Options for Psoriasis
door: Moya, Amena Khatun
Gepubliceerd in: (2023) -
Importance of biologics in rheumatoid arthritis management
door: Riyadh, S. M.
Gepubliceerd in: (2022) -
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
door: Afroza, Halima
Gepubliceerd in: (2024) -
Importance of biologically active agents over other therapies in Rheumatoid Arthritis- a review
door: Mehreen, Elnaj
Gepubliceerd in: (2021) -
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
door: Islam, Nahidul
Gepubliceerd in: (2023)